NumFin

Shenzhen Kangtai Biological Products Co., Ltd.

Sümbol: 300601.SZ

SHZ

22.57

CNY

Turuhind täna

  • 33.5591

    P/E suhe

  • 0.2598

    PEG suhe

  • 24.02B

    MRK Cap

  • 0.01%

    DIV tootlus

Shenzhen Kangtai Biological Products Co., Ltd. (300601-SZ) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Shenzhen Kangtai Biological Products Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

balance-sheet.row.cash-and-short-term-investments

01758.91458.43549.5
3037.8
505.2
634.6
159.7
110.9
149.5
221.7
76.4
216.1

balance-sheet.row.short-term-investments

0563.4440.8725.6
2155.1
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

02819.22414.71991.2
1765.7
1070.6
909.4
549.1
301
173.2
163.4
146
102.2

balance-sheet.row.inventory

0772.9727.81058.2
436.5
228.8
196.1
180.8
141.1
110.8
148.9
140.5
136

balance-sheet.row.other-current-assets

045573.9741.7
104.4
23.6
0.1
100
26.8
27.6
14.9
16.8
2.8

balance-sheet.row.total-current-assets

053965174.97340.7
5344.6
1828.2
1740.2
989.7
579.8
461.2
548.9
379.8
457

balance-sheet.row.property-plant-equipment-net

05756.95176.14116.4
2279.1
1367.2
1166.3
853.3
752.1
599.1
538.4
474.8
395.9

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0504.2475.2736.3
367.4
365.2
204.2
215.8
191.3
177.9
171.4
163.2
221.8

balance-sheet.row.goodwill-and-intangible-assets

0504.2475.2736.3
367.4
365.2
204.2
215.8
191.3
177.9
171.4
163.2
221.8

balance-sheet.row.long-term-investments

02696.22041.399.4
122.6
86.2
30
16.6
6.7
8.9
11.6
11.4
9.6

balance-sheet.row.tax-assets

0630.3708.3558.6
702
271.8
161.5
84.1
50.7
35.5
32.3
35.6
28.1

balance-sheet.row.other-non-current-assets

0101.7210.61297.6
768.8
33.8
34.2
51.2
20.3
51.1
39.5
42
24.3

balance-sheet.row.total-non-current-assets

09689.48611.56808.3
4239.9
2124.2
1596.2
1221
1021.1
872.7
793.2
727.1
679.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

015085.413786.414149
9584.5
3952.4
3336.4
2210.7
1600.9
1333.8
1342.1
1106.9
1136.7

balance-sheet.row.account-payables

0791.2434.1708.2
167.4
116.6
98.4
60.6
35.9
38.3
39.9
41
21.1

balance-sheet.row.short-term-debt

0174.3273.7800.1
23.4
61
49.1
65.9
67.9
76.2
190.5
118.2
38.2

balance-sheet.row.tax-payables

025.9173.498.2
678.5
8.4
22.4
41.6
9.1
7
1.3
1
1

balance-sheet.row.long-term-debt-total

02372.22015.71938
67.8
195
412.6
227.4
281.4
187.9
272.1
375.3
446.7

Deferred Revenue Non Current

0328.7383.1349.5
278.5
122.3
89.4
108.3
145
155.4
95.4
65.1
67.2

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01757.11600.82.8
0
33.9
804.1
47
55.5
58.7
27.2
21.4
15.9

balance-sheet.row.total-non-current-liabilities

02463.62461.22364.1
365.1
328
529.6
363.2
456.6
371.8
413.1
469.8
543.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0521548014982.2
2121.1
1198.2
1503.7
1139.7
865.9
686.7
758.3
734.7
705.5

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

01116.91120.5687.1
684.9
645.2
638.6
421.1
369
369
369
357
357

balance-sheet.row.retained-earnings

02216.71641.12435
1397.9
990.2
616.7
349.7
168.7
82.5
19.7
-11.5
48.1

balance-sheet.row.accumulated-other-comprehensive-income-loss

03117.430362417.5
1753.6
450
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

03090.63187.73627.1
3627
668.8
577.5
300.2
197.3
195.6
195.1
26.6
26.1

balance-sheet.row.total-stockholders-equity

09541.78985.39166.7
7463.4
2754.2
1832.8
1071
735
647.1
583.8
372.2
431.2

balance-sheet.row.total-liabilities-and-stockholders-equity

015085.413786.414149
9584.5
3952.4
3336.4
2210.7
1600.9
1333.8
1342.1
1106.9
1136.7

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

09541.78985.39166.7
7463.4
2754.2
1832.8
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-

Total Investments

03259.6440.899.4
2155.1
86.2
30
16.6
6.7
8.9
11.6
11.4
9.6

balance-sheet.row.total-debt

02546.62289.42738.1
91.2
256
461.8
293.4
349.2
264.1
462.6
493.6
484.9

balance-sheet.row.net-debt

013511271.7-811.4
-791.5
-249.2
-172.8
133.6
238.3
114.6
241
417.1
268.8

Rahavoogude aruanne

Shenzhen Kangtai Biological Products Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012

cash-flows.row.net-income

0-132.71263.4679.2
574.5
435.7
214.7
86.2
62.8
31.2
1.5
11.4

cash-flows.row.depreciation-and-amortization

0200.9404.792.9
83
57.9
57.9
45.8
50.2
48.9
48.4
32.7

cash-flows.row.deferred-income-tax

0-205.550.793.2
20.4
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

01030104.8
131.9
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-604.5-275.6-461.7
-292.7
-180.9
-141.9
-77.7
151.4
3.5
-57.2
-55.3

cash-flows.row.account-receivables

0-488.8273.9-796.5
-178.3
0
0
0
0
0
0
0

cash-flows.row.inventory

0220.7-746.7-209.7
-31.9
-2.2
-53.2
-29.7
40.2
5.8
-20.1
-18.7

cash-flows.row.account-payables

0-131146.5451.3
-102.8
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-205.550.793.2
20.4
-178.7
-88.7
-48
111.3
-2.3
-37.2
-36.6

cash-flows.row.other-non-cash-items

01277.6179.2-68.6
-11.4
23.8
23.3
24.1
13.4
28.5
33.7
16.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-1310.4-2540.4-1226.7
-386.6
-343.7
-189.6
-171.6
-118.7
-89.4
-129.9
-68.7

cash-flows.row.acquisitions-net

00.10.21227.7
0.2
0
189.7
171.6
118.7
100.4
129.9
0

cash-flows.row.purchases-of-investments

0-3518-1100-2625
-0.2
0
-73.2
-6.8
-9
-11
-14.5
0

cash-flows.row.sales-maturities-of-investments

02224.42198.213.7
6.7
106.8
1.9
0.8
2.7
5
1.4
0

cash-flows.row.other-investing-activites

0-2.41.7-1226.7
0.2
0.8
-189.6
-171.6
-118.7
-89.4
-129.9
0

cash-flows.row.net-cash-used-for-investing-activites

0-2606.3-1440.3-3836.9
-379.7
-236.1
-260.9
-177.7
-125
-84.3
-143
-68.7

cash-flows.row.debt-repayment

0-1070.4-26.5-256
-68.8
-65.9
-120.9
-119
-279.9
-168.3
-93.5
-115

cash-flows.row.common-stock-issued

0132.7-2.1-1
0.2
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-20.62.1-0.2
-0.2
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-622.2-220.4-207.3
-178.1
-64.1
-43.1
-17.8
-24.6
-31.2
-31.8
-28.2

cash-flows.row.other-financing-activites

01115.626994243.3
20.2
461.8
310.9
192.9
78.6
317.2
101.7
317.6

cash-flows.row.net-cash-used-provided-by-financing-activities

0-464.92452.23778.7
-226.7
331.8
146.9
56.2
-225.9
117.6
-23.5
174.4

cash-flows.row.effect-of-forex-changes-on-cash

0-1.7-10
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-2527.12663.1381.6
-100.7
432.2
39.9
-43.2
-73
145.3
-140.1
110.9

cash-flows.row.cash-at-end-of-period

0994.13521.3858.1
476.5
577.2
145.1
105.2
148.4
221.3
76
216.1

cash-flows.row.cash-at-beginning-of-period

03521.3858.1476.5
577.2
145.1
105.2
148.4
221.3
76
216.1
105.2

cash-flows.row.operating-cash-flow

0545.71652.3439.8
505.7
336.5
154
78.3
277.9
112.1
26.4
5.3

cash-flows.row.capital-expenditure

0-1310.4-2540.4-1226.7
-386.6
-343.7
-189.6
-171.6
-118.7
-89.4
-129.9
-68.7

cash-flows.row.free-cash-flow

0-764.7-888.1-786.8
119.1
-7.2
-35.7
-93.3
159.2
22.7
-103.5
-63.5

Kasumiaruande rida

Shenzhen Kangtai Biological Products Co., Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 300601.SZ brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

income-statement-row.row.total-revenue

03451.83157.43652.1
2261.2
1943.3
2016.9
1161.2
551.9
452.7
303.4
250.5
122.5

income-statement-row.row.cost-of-revenue

0622.8499.9986.4
226.3
163.7
179.4
136.3
118.3
165.5
96.6
77.9
30.2

income-statement-row.row.gross-profit

02829.12657.52665.7
2034.9
1779.7
1837.5
1024.8
433.6
287.3
206.8
172.6
92.3

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-118.874.473.9
110.5
93
7.8
-4.2
13.6
2.3
-1.4
34
42.8

income-statement-row.row.operating-expenses

02054.22020.81071.9
1291.4
1107.3
1325.2
759.5
324.6
208
144.4
159.7
107.6

income-statement-row.row.cost-and-expenses

026772520.82058.4
1517.7
1271
1504.6
895.9
442.8
373.4
241
237.7
137.7

income-statement-row.row.interest-income

0115.6132.6114.9
24.1
3.5
6.6
0.5
0.4
1.6
0.8
0.4
0

income-statement-row.row.interest-expense

0113.710954.5
2.3
8.9
23.9
2.2
2.1
9
20.3
15.6
7.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0165.5-1085.3-13
-3
5.6
-23.2
-27.3
-10.1
-8.2
-27.9
-12.9
29.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-118.874.473.9
110.5
93
7.8
-4.2
13.6
2.3
-1.4
34
42.8

income-statement-row.row.total-operating-expenses

0165.5-1085.3-13
-3
5.6
-23.2
-27.3
-10.1
-8.2
-27.9
-12.9
29.8

income-statement-row.row.interest-expense

0113.710954.5
2.3
8.9
23.9
2.2
2.1
9
20.3
15.6
7.9

income-statement-row.row.depreciation-and-amortization

0240.7200.9676.6
95.5
113.7
57.9
57.9
45.8
50.2
48.9
48.4
32.7

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0774.87471452.2
775.4
657.8
481.3
242.2
85.7
69.2
36
-34
-28.3

income-statement-row.row.income-before-tax

0940.3-338.21439.2
772.4
663.4
489.1
238
99
71.1
34.5
-0.1
14.5

income-statement-row.row.income-tax-expense

079-205.5175.9
93.2
88.9
53.4
23.3
12.8
8.3
3.3
-1.6
3.1

income-statement-row.row.net-income

0861.3-132.71263.4
679.2
574.5
435.7
214.7
86.2
62.8
31.2
1.5
11.4
Sarnased aktsiad
Sind võib huvitada ka:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

Korduma kippuv küsimus

Mis on Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) koguvara?

Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) koguvara on 15085358535.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.832.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 0.165.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.224.

Mis on ettevõtte kogutulu?

Kogutulu on 0.213.

Mis on Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 861303903.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 2546554090.000.

Mis on tegevuskulude arv?

Tegevuskulud on 2054244031.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.